Literature DB >> 31570164

MTA1 coregulator regulates LDHA expression and function in breast cancer.

Rohith Kumar Guddeti1, Prerna Bali1, Prashanthi Karyala2, Suresh B Pakala3.   

Abstract

Metastasis Associated Protein1 (MTA1) is a chromatin modifier and its expression is significantly associated with prognosis of many cancers. However, its role in glucose metabolism remains unexplored. Here, we report that MTA1 has a significant role in glucose metabolism where MTA1 regulates the LDHA expression and activity and subsequently its function in breast cancer motility. The results showed that MTA1 expression is positively correlated with the LDHA expression levels in breast cancer patients. Further, it was found that MTA1 is necessary for the optimal expression of LDHA. The underlying molecular mechanism involves the interaction of MTA1 with c-Myc and recruitment of MTA1-c-Myc complex on to the LDHA promoter to regulate its transcription. Consequently, the LDHA knock down using LDHA specific siRNA in MCF7 cells stably expressing MTA1 reduced the migration of MCF7 cells. Altogether these findings revealed the regulatory role for MTA1 in LDHA expression and its resulting biological function.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; LDHA and glucose metabolism; MTA1

Year:  2019        PMID: 31570164     DOI: 10.1016/j.bbrc.2019.09.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  MTA1 aggravates experimental colitis in mice by promoting transcription factor HIF1A and up-regulating AQP4 expression.

Authors:  Ping Li; Dong-Ping Shi; Tao Jin; Dong Tang; Wei Wang; Liu-Hua Wang
Journal:  Cell Death Discov       Date:  2022-06-28

Review 2.  Oxygen and metabolic reprogramming in the tumor microenvironment influences metastasis homing.

Authors:  Vinod S Bisht; Kuldeep Giri; Deepak Kumar; Kiran Ambatipudi
Journal:  Cancer Biol Ther       Date:  2021-10-25       Impact factor: 4.742

3.  Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.

Authors:  Xinyu Gu; Jun Guan; Jia Xu; Qiuxian Zheng; Chao Chen; Qin Yang; Chunhong Huang; Gang Wang; Haibo Zhou; Zhi Chen; Haihong Zhu
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

4.  Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma.

Authors:  Yubo Cao; Xiaomei Lu; Yue Li; Jia Fu; Hongyuan Li; Xiulin Li; Ziyou Chang; Sa Liu
Journal:  PeerJ       Date:  2020-12-02       Impact factor: 2.984

5.  Metastasis-associated gene 1 (MTA1) enhances cisplatin resistance of malignant pleural mesothelioma by ATR-Chk1-mediated DNA repair.

Authors:  Caihua Xu; Yufeng Hu; Bin Chen; Dapeng Li; Rongrui Liang; Meng Shen; Mengyao Wu; Min Tao
Journal:  Ann Transl Med       Date:  2021-04

Review 6.  Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer.

Authors:  Miaomiao Huo; Jingyao Zhang; Wei Huang; Yan Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-24

7.  Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.

Authors:  Minhua Wu; Limu Wen; Yuxin Zhou; Weizhu Wu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

8.  Buffalo Milk Whey Activates Necroptosis and Apoptosis in a Xenograft Model of Colorectal Cancer.

Authors:  Nunzio Antonio Cacciola; Angela Salzano; Nunzia D'Onofrio; Tommaso Venneri; Paola De Cicco; Francesco Vinale; Orsolina Petillo; Manuela Martano; Paola Maiolino; Gianluca Neglia; Ciro Campanile; Lorella Severino; Carmine Merola; Francesca Borrelli; Maria Luisa Balestrieri; Giuseppe Campanile
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

9.  Expression and Clinical Significance of Lactate Dehydrogenase A in Colon Adenocarcinoma.

Authors:  Yutong Wang; Hui Nie; Zhiming Liao; Xiaoyun He; Zhijie Xu; Jianhua Zhou; Chunlin Ou
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.